BenevolentAI
AI-powered drug discovery for biopharma
Score
60
User Rating
3.0
Free/Trial Support
Supported
Starting Price
--
Last Updated
Apr 24, 2026
Overview
What is BenevolentAI?
BenevolentAI (Euronext Amsterdam: BAI) is a company that applies advanced AI to accelerate biopharma drug discovery. Their next-generation platform targets the complex decisions that drive R&D, providing life science intelligence. They build technology in the service of science, bringing together science and technology teams to push AI and machine learning to new limits. They leverage their knowledge graph and proprietary ontologies to support scientists and executives in leveraging cutting-edge AI with confidence and precision.
What is BenevolentAI used for?
Top Features
- AI-driven drug discovery platform
- Knowledge graph and proprietary ontologies
- Life science intelligence
How to use BenevolentAI?
The website provides information about BenevolentAI's platform and its applications in drug discovery. Users can explore the company's philosophy, contact them for more information, and access resources like regulatory archives, terms and conditions, privacy policy, cookie declaration, accessibility information, and a sitemap.
Alternative Tools
No alternative tools found
Pros & Cons
No Data
Use Cases
- Accelerating the identification of potential drug candidates
- Improving the efficiency of drug development processes
- Providing insights into complex biological systems
BenevolentAI Pricing
Free PlanSubscription Plan
No detailed pricing information available
User Reviews
3.0
out of 5
3.0
No reviews yet
Be the first to review this tool!